The next giant step for microbes – Nature Biotechnology
A microbiome therapy is approved by the FDA for treatment of Clostridioides difficile. What’s next?
A microbiome therapy is approved by the FDA for treatment of Clostridioides difficile. What’s next?
Nature Biotechnology – Tumor-reactive T cell receptors are predicted based on single-cell RNA sequencing and single-cell T cell receptor sequencing.
Nature Biotechnology – Proteome-wide measurements of dose–response curves for 144 drugs reveal drug mechanisms of action.
Anticoagulant treatments are crucial for managing many conditions, such as heart disease, stroke and venous thrombosis. Current options, however, carry an
SNIPR Biome, a Copanhagen-based clinical-stage biotech company pioneering precision medicines using CRISPR technology for microbial gene therapy, has secured
Nature Biotechnology’s Forum podcast explores biotech’s latest scientific publications, found in Nature Biotechnology and elsewhere, through discussions with today’s leading researchers.
Des scientifiques de l’Université de Genève (UNIGE), en collaboration avec des collègues en Australie, ont mis au point un nouveau type d’anticoagulant dont l’action peut…
New MSK research provides two examples of computational tools developed at MSK that leverage data about cells’ locations to expand our understanding of cancer.
In one of the largest and most accomplished citizen science projects of all time, millions of gamers playing a very popular looter-shooter video game have…
Nature Reviews Genetics – In this Tools of the Trade article, Samuel Gould explains how prime editing sensors can improve experimental efficiency and can be…
Millions of gamers could help cure your next stomach ache, and more.